Abstract

BackgroundCentral lymph node metastasis (CLNM) occurs frequently in patients with papillary thyroid cancer (PTC), but performing prophylactic central lymph node dissection is still controversial. There are no reliable models for predicting CLNM. This study aimed to develop predictive models for CLNM by machine learning (ML) algorithms.MethodsPatients with PTC who underwent initial thyroid resection at our hospital between January 2018 and December 2019 were enrolled. A total of 22 variables, including clinical characteristics and ultrasonography (US) features, were used for conventional univariate and multivariate analysis and to construct ML-based models. A 5-fold cross validation strategy was used for validation and a feature selection approach was applied to identify risk factors.ResultsThe areas under the receiver operating characteristic curve (AUC) of 7 models ranged from 0.680 to 0.731. All models performed significantly better than US (AUC=0.623) in predicting CLNM (P<0.05). In decision curve, most of the models also performed better than US. The gradient boosting decision tree model with 7 variables was identified as the best model because of its best performance in both ROC (AUC=0.731) and decision curves. Based on multivariate analysis and feature selection, young age, male sex, low serum thyroid peroxidase antibody and US features such as suspected lymph nodes, microcalcification and tumor size > 1.1 cm were the most contributing predictors for CLNM.ConclusionsIt is feasible to develop predictive models of CLNM in PTC patients by incorporating clinical characteristics and US features. The ML algorithm may be a useful tool for the prediction of lymph node metastasis in thyroid cancer.

Highlights

  • Thyroid cancer is the most common malignant endocrine carcinoma [1, 2]

  • Since very few studies have developed machine learning (ML)-based predictive models for thyroid cancer, this study aims to construct multiple ML-based models for the preoperative prediction of Central lymph node metastasis (CLNM) and identify risk factors associated with CLNM in patients with Papillary thyroid cancer (PTC)

  • Univariate analysis (Table 2) showed that CLNM was significantly associated with age, sex, fasting blood glucose (FBG), free T3 (FT3), free T4 (FT4), thyroid peroxidase antibody (TPO-Ab) and US features such as tumor size, microcalcification, irregular shape and suspected lymph nodes (LNs) (P

Read more

Summary

Introduction

Thyroid cancer is the most common malignant endocrine carcinoma [1, 2]. With the rapid advancement of molecular and radiological technologies, the diagnostic accuracy on thyroid cancer has been improved [3]. Central lymph node metastasis (CLNM) occurs frequently in PTC, with a prevalence that could be as high as 40% to 90% [7]. Central lymph node dissection (CLND) is required for these patients. There are some patients with microscopic and undetectable CLNM who are hard to evaluate by preoperative examination [9], though the significant difference of prognoses among micrometastatic PTC patients who is typically resected with prophylactic CLND appears minimal [10], but whether micrometastases could cause recurrence or distant metastasis remains unclear. Central lymph node metastasis (CLNM) occurs frequently in patients with papillary thyroid cancer (PTC), but performing prophylactic central lymph node dissection is still controversial. This study aimed to develop predictive models for CLNM by machine learning (ML) algorithms

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.